`__________________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`__________________
`
`CIPLA LIMITED,
`Petitioner
`
`v.
`
`ALCON RESEARCH, LTD,
`Patent Owner
`__________________
`
`Patent No. 9,533,053
`Issue Date: January 3, 2017
`Title: HIGH CONCENTRATION OLOPATADINE
`OPHTHALMIC COMPOSITION
`__________________
`
`Inter Partes Review No. IPR2018-01021
`__________________
`
`
`PATENT OWNER’S MANDATORY NOTICES
`
`37 C.F.R. 42.8(a)(2)
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Pursuant to 37 C.F.R. § 42.8(a)(2), the Patent Owner submits the following
`
`mandatory notices:
`
`(1) Real parties-in-interest.
`
`Alcon Research, Ltd. is a corporation organized and existing under the laws
`
`of the State of Delaware and has a principal place of business at 6201 South
`
`Freeway, Fort Worth, Texas 76134. Alcon is the assignee of U.S. Patent No.
`
`9,533,053 (the “’053 patent”).
`
`Alcon Research, Ltd. is a wholly-owned subsidiary of Novartis AG, a
`
`corporation organized and existing under the laws of Switzerland, having an office
`
`and place of business at Lichtstrasse 35, CH-4056 Basel, Switzerland.
`
`(2) Related matters.
`
`The following matters, in which the ’053 patent has been asserted, could
`
`affect, or could be affected by, a decision in this proceeding:
`
` Argentum Pharmaceuticals LLC v. Alcon Research, Ltd., IPR2016-
`00544 (P.T.A.B.)
` Apotex Inc. and Apotex Corp. v. Alcon Research, Ltd., IPR2016-
`01640 (P.T.A.B.)
` Alcon Research, Ltd. v. Watson Laboratories, Inc., Actavis Pharma,
`Inc., and Actavis Inc., 1:15-cv-1159 (D. Del.).
` Alcon Research, Ltd. v. Apotex Inc. and Apotex Corp., 1:16-cv-00906
`(D. Del.)
` Alcon Research, Ltd. v. Lupin Limited et al., 1:16-cv-00195 (D. Del.)
` Alcon Research, Ltd. v. Cipla Limited et al., 1:17-cv-01244 (D. Del.)
`
`2
`
`
`
`
`
`
`
`
`
`
`
`(3) Lead and back-up counsel.
`
`The Patent Owners designate the following lead and back-up counsel:
`
`A. Lead Counsel
`
`
`
`Christopher A. Suarez
`
`Reg. No. 72,553
`
`Williams & Connolly LLP
`725 Twelfth Street, N.W.
`Washington, D.C. 20005
`202-434-5279 (Telephone)
`202-434-5029 (Facsimile)
`csuarez@wc.com
`
`
`B. Backup Counsel
`
`
`David M. Krinsky
`Reg. No. 72,339
`Williams & Connolly LLP
`725 Twelfth Street, N.W.
`Washington, D.C. 20005
`202-434-5338 (Telephone)
`202-434-5029 (Facsimile)
`dkrinsky@wc.com
`
`Peter J. Waibel
`Reg. No. 43,228
`Novartis Pharmaceutical Corp.
`One Health Plaza, Bldg. 430
`East Hanover, NJ 07936
`862-778-7838 (Telephone)
`peter.waibel@novartis.com
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Powers of attorney appointing these attorneys to transact all business in this
`
`proceeding are submitted together with this mandatory notice information.
`
`
`
`
`
`3
`
`
`
`(iii) Hand-delivery address: Christopher A. Suarez
`Williams & Connolly LLP
` 725 Twelfth Street, N.W.
` Washington D.C. 20005
`
`
`
`
`202-434-5279
`
`(iv) Telephone number:
`
`Facsimile number:
`
`Counsel for Patent Owner consent to electronic service by email at
`
`
`
`
`
`(4) Service information.
`
`Counsel for Patent Owner submits the following service information:
`
`
`(i)
`
`Electronic mail address:
`
`
`(ii) Postal mailing address:
`
`csuarez@wc.com
`dkrinsky@wc.com
`peter.waibel@novartis.com
`pazeo-IPR@wc.com
`
`Christopher A. Suarez
`Williams & Connolly LLP
`725 Twelfth Street, N.W.
`Washington D.C. 20005
`
`(v)
`
`
`
`202-434-5029
`
`csuarez@wc.com, dkrinsky@wc.com, peter.waibel@novartis.com, and pazeo-
`
`IPR@wc.com.
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`4
`
`
`
`
`
`Dated: June 26, 2018
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Respectfully submitted,
`
`
` /Christopher A. Suarez/
`
`Christopher A. Suarez
`Reg. No. 72,553
`Williams & Connolly LLP
`725 Twelfth Street, N.W.
`Washington, D.C. 20005
`202-434-5279 (Telephone)
`202-434-5029 (Facsimile)
`csuarez@wc.com
`
`
`
`5
`
`
`
`
`
`CERTIFICATE OF SERVICE
`
`The undersigned hereby certifies that the foregoing Mandatory Notice
`
`Information Pursuant to 37 C.F.R. § 42.8(a)(2) through the Patent Review
`
`Processing System as well as by delivering a copy via electronic mail on the
`
`following attorneys of record for the petitioner:
`
`
`
`
`
`Jitendra Malik, Ph.D. (Reg. No. 55,823)
`Katten Muchin Rosenman LLP
`555 S. Tryon Street, Suite 2900
`Charlotte, NC 28202-4213
`jitty.malik@kattenlaw.com
`
`Brian Sodikoff (Reg. No. 54,697)
`Katten Muchin Rosenman LLP
`525 West Monroe Street
`Chicago, IL 60661-3693
`brian.sodikoff@kattenlaw.com
`
`Alissa M. Pacchioli (Reg. No. 74,252)
`Katten Muchin Rosenman LLP
`555 S. Tryon Street, Suite 2900
`Charlotte, NC 28202-4213
`alissa.pacchioli@kattenlaw.com
`
`
`
`6
`
`